Peiying Zuo

EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma

Jonathan E. Rosenberg, Srikala S. Sridhar, Jingsong Zhang et al. · Journal of Clinical Oncology · 2020 · 311 citations · Full text

Mathematical Model of Nucleotide Regulation on Airway Epithelia

Peiying Zuo, Maryse Picher, Seiko F. Okada et al. · Journal of Biological Chemistry · 2008 · 38 citations · Full text

Glucose and lipid effects of the ileal apical sodium‐dependent bile acid transporter inhibitor <scp>GSK2330672</scp> : double‐blind randomized trials with type 2 diabetes subjects taking metformin

Derek J. Nunez, Xiaozhou Yao, Jian Lin et al. · Diabetes Obesity and Metabolism · 2016 · 33 citations

Integration of modeling and simulation to support changes to ondansetron dosing following a randomized, double‐blind, placebo‐, and active‐controlled thorough QT study

Peiying Zuo, Lynda J. Haberer, Fang Lei et al. · The Journal of Clinical Pharmacology · 2014 · 29 citations · Full text

Maximum Mean Ddqtcf, Ich E14 Guidelines, Therapeutic Drug Monitoring +12

Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective

Chunze Li, Rajeev Menon, Markus Walles et al. · Clinical Pharmacology & Therapeutics · 2021 · 19 citations

Drug Target, Immunology, Immunotherapy +19